Adult patients with pulmonary arterial hypertension due to congenital heart disease: a review on advanced medical treatment with bosentan

Pulmonary arterial hypertension (PAH) is a progressive disease with poor survival outcome. PAH is classified by the 2009 updated clinical classification of pulmonary hypertension and a major subgroup is PAH due to congenital heart disease (CHD) with systemic-to-pulmonary shunt. CHD-PAH is a result o...

Full description

Saved in:
Bibliographic Details
Main Authors: Schuuring, Mark J, Vis, Jeroen C, Duffels, Marielle G, Bouma, Berto J, Mulder, Barbara JM
Format: Artigo
Language:Inglês
Published: Dove Medical Press 2010
Subjects:
Review
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2940744/
https://ncbi.nlm.nih.gov/pubmed/20856682
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items